The basic principle in the Biocidal Products Regulation ((EU) No 528/2012 (BPR)) is that a biocidal product (BP) must be authorised before it can be made available on the market or used in the European Union (EU)/ European Economic Area (EEA).
This takes place in two consecutive steps. As the first step, the active substance is evaluated and, provided the criteria are fulfilled, is then approved in a specified product-type (PT). The second step is the authorisation of each BP consisting of, containing or generating the approved active substance(s).
This document concerns the first step, approval of active substances.
October 2016
Collegati
ID 21266 | 30.01.2024 / Allegato studio completo EFSA
La Commissione europea ha chiesto all'EFSA di aggiornare la valuta...
ID 10721 | 07.05.2020
L’ozono CAS 10028-15-6 (dal greco ozein, odore) è una molecola costituita da 3 atomi di ossigeno (O3). La sua struttura ...
ID 19929 | Last update: 05.07.2023
REACH Authorisation Decisions List of authorisation decisions adopted on the basis of Article 64 of Regul...
Testata editoriale iscritta al n. 22/2024 del registro periodici della cancelleria del Tribunale di Perugia in data 19.11.2024
